LB-3. Oral Tebipenem Pivoxil Hydrobromide is Non-inferior to IV Ertapenem in Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) – Results from the Pivotal ADAPT-PO Study

BACKGROUND: Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is an orally bioavailable prodrug that is rapidly converted in plasma to the carbapenem, tebipenem. Tebipenem has in vitro activity against select multidrug-resistant Gram-negative pathogens, including fluoroquinolone-resistant and extended-spe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Muir, Lori A, Walpole, Susannah M, Warfel, Patricia A, Kwak, Hanna, Phelan, Anne-Marie, Moore, Gary E, Jain, Akash, Keutzer, Tim, Dane, Aaron, Melnick, David, Talley, Angela K
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Late Breaker Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776701/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa515.1900
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky